Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Tango Therapeutics, Inc. | Chief Scientific Officer | Common Stock | 168K | $1.41M | $8.39 | Mar 1, 2023 | Direct |
Tango Therapeutics, Inc. | Chief Scientific Officer | Stock Option (Right to Buy) | 190K | Mar 1, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TNGX | Tango Therapeutics, Inc. | Mar 1, 2023 | 2 | $0 | 4 | Mar 2, 2023 | Chief Scientific Officer |
TNGX | Tango Therapeutics, Inc. | Feb 1, 2022 | 1 | $0 | 4 | Feb 3, 2022 | Chief Scientific Officer |
TNGX | Tango Therapeutics, Inc. | Aug 12, 2021 | 1 | $0 | 4 | Aug 16, 2021 | Chief Scientific Officer |
TNGX | Tango Therapeutics, Inc. | Aug 10, 2021 | 0 | $0 | 3 | Aug 12, 2021 | Chief Scientific Officer |